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Summary
Astrocytes exhibit a complex, branched morphology, allowing them to functionally interact with numerous blood vessels, neighboring
glial processes and neuronal elements, including synapses. They also respond to central nervous system (CNS) injury by a process
known as astrogliosis, which involves morphological changes, including cell body hypertrophy and thickening of major processes.
Following severe injury, astrocytes exhibit drastically reduced morphological complexity and collectively form a glial scar. The
mechanistic details behind these morphological changes are unknown. Here, we investigate the regulation of the actin-nucleating
Arp2/3 complex in controlling dynamic changes in astrocyte morphology. In contrast to other cell types, Arp2/3 inhibition drives the
rapid expansion of astrocyte cell bodies and major processes. This intervention results in a reduced morphological complexity of
astrocytes in both dissociated culture and in brain slices. We show that this expansion requires functional myosin II downstream of
ROCK and RhoA. Knockdown of the Arp2/3 subunit Arp3 or the Arp2/3 activator N-WASP by siRNA also results in cell body
expansion and reduced morphological complexity, whereas depleting WAVE2 specifically reduces the branching complexity of
astrocyte processes. By contrast, knockdown of the Arp2/3 inhibitor PICK1 increases astrocyte branching complexity. Furthermore,
astrocyte expansion induced by ischemic conditions is delayed by PICK1 knockdown or N-WASP overexpression. Our findings
identify a new morphological outcome for Arp2/3 activation in restricting rather than promoting outwards movement of the plasma
membrane in astrocytes. The Arp2/3 regulators PICK1, and N-WASP and WAVE2 function antagonistically to control the complexity
of astrocyte branched morphology, and this mechanism underlies the morphological changes seen in astrocytes during their response
to pathological insult.
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Introduction
Astrocytes are the most abundant glial cell type in the central
nervous system (CNS) and have multiple supportive and
regulatory roles in neuronal function (Sofroniew and Vinters,
2010). They are probably best known for their homeostatic role,
but recent studies have demonstrated an active role of astrocytes in
regulating synaptogenesis, synaptic transmission and plasticity
through their physical interactions with neurons and specifically
synapses (Nedergaard and Verkhratsky, 2012). Each astrocyte
possesses its own domain in the CNS and contacts surrounding
synapses through a complex network of branched processes. In
addition to their functions in the healthy CNS, astrocytes respond
to most pathological conditions, including ischemia, with dramatic
morphological changes in a process known as reactive astrogliosis.
The first signs of astrogliosis are an increase in cell body size and a
thickening of the major processes, and, upon severe injuries,
astrocytes lose their ‘stellate’ morphology and form physical
barriers, known as glial scars. These have beneficial short-term
effects by preventing the spread of inflammation and pathogens
into the surrounding tissue. However, the glial scar is permanent
and inhibits neuronal regeneration (Robel et al., 2011). The actin-
based mechanisms that underlie these drastic changes in
morphology in response to pathological insult are unknown, and
an increase in knowledge of these mechanisms is crucial to a better
understanding of neurological disease processes.
A major modulator of actin dynamics is the Arp2/3 complex,
which initiates polymerization of new actin filaments (Pollard and
Cooper, 2009). Current models on cell motility propose a role for
Arp2/3 in pushing the lamellipodial plasma membrane forwards by
forming branched actin arrays (Pollard and Cooper, 2009). In
accordance with this model, Arp2/3 inactivation leads to impaired
cell motility and shrinkage or outgrowth inhibition. The isolated
Arp2/3 complex is inactive and must be activated by specific
nucleation-promoting factors (NPFs) (Pollard and Cooper, 2009).
Within the growing lists of NPFs, the WAVE complex and N-
WASP are the best characterized. The WAVE complex is crucial
for lamellipodia formation and membrane ruffling, whereas
numerous studies indicate a prominent role for N-WASP in
endocytosis and vesicle motility (Rottner and Stradal, 2011). To
This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution
and reproduction in any medium provided that the original work is properly attributed.
Research Article 3873
J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
date, there are no reports describing the function of WAVE or
N-WASP in astrocytes. Endogenous Arp2/3 inhibitor proteins
include PICK1, which inhibits actin nucleation through direct
binding to the Arp2/3 complex (Rocca et al., 2008; Nakamura
et al., 2011). PICK1-mediated inhibition of Arp2/3-mediated
actin polymerization has been demonstrated in neurons, but its
role in regulating actin dynamics in other cell types is
unexplored.
In the present study, we show that tonic Arp2/3 activity is
required for maintaining the typical stellate morphology of
astrocytes in dissociated cultures and in brain tissue. In striking
contrast to other cell types, Arp2/3 inhibition evokes cell body
Fig. 1. Inactivation of the Arp2/3 complex in astrocytes results in an expanded destellated morphology. (A) Phase-contrast live-cell imaging of serum-
starved cultured astrocytes in the presence of forskolin with or without the Arp2/3 inhibitor CK-548. Scale bars: 20 mm. (B) Western blot analysis of astrocytes
transfected either with a control (siControl) or Arp3 (siArp3)-specific siRNA. Arp3 expression was determined using an Arp3-specific antibody, and GAPDH
immunoreactivity was used as loading control. (C) Confocal images of astrocytes transfected with Arp3 siRNA or control siRNA followed by serum starvation
and forskolin treatment. Arp3 expression was visualized by immunostaining for Arp3 (red) and F-actin by phalloidin staining (green). Arp3-depleted cells
(arrowheads) do not have a stellated morphology, compared with Arp3-positive cells (arrows), which do. Scale bars: 10 mm. (D) Schematic example to illustrate
representative differences in cell outlines and cell areas of polygonal (left) and stellate (right) astrocytes. (E) Frequency analysis of astrocyte complexity in Arp3-
knockdown and control cells after forskolin treatment. Cells were analyzed regarding the ratio of cell outline and cell area. Cells with a cell outline to cell area
#0.2 are defined as polygonal. High values for the cell-outline:cell-area ratios correspond to high levels of astrocyte complexity (n5300 cells per condition from
three independent experiments). (F) Quantification of the proportion of polygonal cells as shown in C and E. ***P,0.0005 (unpaired Student’s t-test). (G) Phase
contrast live-cell imaging of serum-starved astrocytes previously treated with forskolin and kept in serum-free medium in the absence or presence of CK-548.
Scale bars: 10 mm. (H) Frequency analysis of astrocyte complexity of CK-548- and DMSO-treated cells (300 cells per condition from three independent
experiments). (I) Quantification of the proportion of polygonal cells shown in G and I. **P,0.005 (Student’s unpaired t-test). (J) Confocal images of stellated
astrocytes before (upper panels), after 5 min of CK-548 incubation. Arp2/3 localization and actin filaments were visualized by immunostaining for Arp3 (red) and
phalloidin staining for F-actin (green). Note that Arp3 is enriched along processes and the plasma membrane of stellated astrocytes (arrows). Scale bars: 10 mm.
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expansion in astrocytes. Furthermore, we identify N-WASP,
WAVE2 and PICK1 as antagonistic endogenous Arp2/3
regulators involved in the regulation of astrocyte morphology,
particularly under conditions relating to ischemic injury.
Results
Inactivation of the Arp2/3 complex evokes cell expansion
in astrocytes
To study the role of the Arp2/3 complex in astrocytes, we used the
compound CK-548, which specifically blocks Arp2/3 dependent
actin nucleation and has been successfully used on monocytes and
neurons (Nolen et al., 2009; Tahirovic et al., 2010).
Rat astrocytes grow as polygonal cells in serum-rich medium,
so we used a previously established protocol to drive astrocytes
into a stellate morphology analogous to astrocytes in native tissue
(Ramakers and Moolenaar, 1998). Forskolin stimulates actin
bundle disassembly, cytoplasmic shrinkage and process
outgrowth (Fig. 1A; supplementary material Movie 1). These
morphological changes are completely blocked by CK-548
application (Fig. 1A; supplementary material Movie 2).
To further analyze the role of Arp2/3 activity in regulating
astrocyte morphology, we transfected astrocytes with a previously
verified Arp3-specific siRNA (Korobova and Svitkina, 2008). Five
days post-transfection, Arp3 expression was reduced to
30.2%64.8 (s.d.) compared with that in controls (Fig. 1B). In
Arp3-deficient astrocytes, forskolin-induced stellation was
completely blocked (Fig. 1C, arrowheads), whereas cells with
higher Arp3 expression acquire a stellated morphology (Fig. 1C,
arrows). To quantify the morphological changes, we established a
method to distinguish between cell shapes ranging from polygonal
to stellate astrocyte morphologies. Higher values of the ratio
between the cell outline and the cell area indicate greater astrocyte
complexity, that is a greater degree of stellation, whereas cells with
values ranging from 0 to 0.2 have a polygonal shape (Fig. 1D).
Arp3 knockdown blocks the development of the typical stellate
astrocyte morphology in 76.6%67.8 of cells, whereas under
control conditions only 19.5%65.3 of astrocytes fail to respond to
forskolin (Fig. 1E,F). Arp3 knockdown therefore resembles the
phenotype observed with the pharmacological inhibitor CK-548.
To investigate the effect of Arp2/3 inhibition on previously
stellated astrocytes, we treated astrocytes with forskolin, and
after washout incubated with CK-548. In the absence of any other
extrinsic signal, Arp2/3 inhibition evokes the expansion of
astrocytes towards a polygonal morphology (Fig. 1G;
supplementary material Movie 4). DMSO-treated control cells
retain their stellate morphology (Fig. 1G; supplementary material
Movie 3). The changes in astrocyte morphology triggered by
Arp2/3 inhibition were largely complete within 45–60 min, and
76%63.7 of cells were defined as being polygonal after 2 h of
CK-548 incubation (Fig. 1H,I). Arp2/3 inhibition by CK-548 also
caused rapid changes in Arp2/3 localization. Instead of being
enriched along processes and the plasma membrane, the Arp2/3
complex had a scattered localization immediately after its
inactivation by CK-548 (Fig. 1J). To investigate whether the
unexpected effect of Arp2/3 inhibition reflects a different protein
expression level of the Arp2/3 complex compared with that in
other cell types, we analyzed the expression level of the key
subunit Arp3 in astrocytes, other primary cells and two cell lines
including a cancer cell line (supplementary material Fig. S1). We
did not detect any significant differences in Arp3 levels in
astrocytes compared with that in neurons or primary embryonic
fibroblasts (supplementary material Fig. S1A,B). In summary,
these results demonstrate an unexpected expansion of cultured
astrocytes as a consequence of Arp2/3 inhibition.
To study whether Arp2/3 inhibition would evoke analogous
changes in astrocytes in intact tissue, we exposed acute cortical
slices from P14 rats to CK-548 (Fig. 2). To detect changes in
astrocyte morphology within tissue, we established a new
technique to combine whole-mount immunohistochemistry with
a recently published method for tissue clearance (see Materials
and Methods) (Fig. 2A) (Hama et al., 2011), allowing antibody
labeling for astrocytic markers observable deep within the tissue
by confocal microscopy (supplementary material Movie 5). We
used antibodies specific for glial fibrillary acidic protein (GFAP),
which labels the main astrocytic processes, and S100b, which
localizes to the cytoplasm and, to a minor extent, to membranes
(Sen and Belli, 2007) (Fig. 2B). S100b staining therefore acts as
a useful marker to define the fine details of complex astrocyte
morphology (Fig. 2B, supplementary material Movie 6). We
used a filament-tracing algorithm in Imaris software, originally
designed for quantifying dendritic spines on neurons. We defined
GFAP-positive processes as ‘dendrites’ from where smaller
processes (‘spines’) originate and branch (Fig. 2C). To study the
effect of Arp2/3 inhibition on astrocytes, we incubated cortical
slices with either CK-548 or DMSO in oxygenated artificial
cerebrospinal fluid (aCSF) and performed quantitative analyzes
of astrocyte morphology. Fig. 2D shows that CK-548 has no
effect on the length of the longest GFAP-positive process.
Astrocytes from control slices exhibit a highly complex
arborization of fine, branched S100b-positive processes
emerging from the main shafts. In contrast, astrocytes in CK-
548-treated slices show fewer, thicker S100b-containing
protrusions compared with the number in control cells
(Fig. 2C). To quantify these changes in astrocyte complexity,
we performed Sholl analyzes taking GFAP- as well as S100b-
positive processes into account. Pharmacological inhibition of the
Arp2/3 complex leads to a dramatic reduction in astrocyte
complexity compared with that in control cells (Fig. 2E). In
addition, we studied whether the volume of individual S100b-
containing protrusions changes in response to Arp2/3 inhibition.
We observed a decrease in the number of small protrusions,
whereas bigger processes become more frequent (Fig. 2G).
Furthermore, inhibition of Arp2/3 activity causes a marked
increase in cell body volume (Fig. 2F). These experiments
demonstrate that acute inhibition of the Arp2/3 complex also
evokes the expansion of astrocytes within intact tissue.
Myosin II and formins drive the cell expansion of
astrocytes during Arp2/3 inhibition
To investigate the molecular mechanisms responsible for the
Arp2/3-dependent expansion of astrocytes, we incubated stellated
astrocyte cultures with CK-548 in conjunction with small
inhibitors specific for other cytoskeletal components (Fig. 3A–
E). Cells treated with CK-548 or DMSO alone served as controls
(Fig. 3A,B). The formin inhibitor SMIFH2 (Rizvi et al., 2009)
appeared to cause a small reduction in the effect of CK-548 on
cell expansion (Fig. 3C). However, statistical analysis indicated
that there was no significant difference in the proportion of
polygonal cells in astrocytes treated with CK-548 and SMIFH2
compared with in astrocytes treated with CK-548 alone (Fig. 3F).
The myosin II inhibitor blebbistatin more completely blocked
astrocyte expansion (Fig. 3D,F). This result led us to test
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upstream regulators of myosin II in the presence of CK-548. We
used Y-27632 to inhibit the Rho-dependent kinase (ROCK),
which activates myosin II (Vicente-Manzanares et al., 2009). The
efficiency of Y-27632 in counteracting the effects of Arp2/3
inhibition on astrocyte morphology is similar to that of
blebbistatin (Fig. 3D–F).
The opposing effect of the inhibitor Y-27632- on CK-548-
treated astrocytes suggests changes in upstream signaling
pathways mediated by the small GTPase RhoA. We performed
pulldown assays to isolate GTP-bound GTPases from astrocytes
treated with either DMSO or CK-548 after forskolin washout. In
comparison with control cells, the level of GTP-bound RhoA is
significantly increased in CK-548-treated astrocytes (Fig. 3G). We
also measured the amount of active Rac1 in the treated astrocytes. In
contrast to RhoA, no significant changes occurred in the level of
GTP-bound Rac1 (Fig. 3H). These results indicate that the expansion
of astrocytes is accompanied with increased RhoA activity.
N-WASP is a crucial Arp2/3 activator in astrocyte
morphology
To investigate which endogenous Arp2/3 regulatory proteins are
required for the maintenance of astrocyte morphology, we
knocked down expression of the Arp2/3 activators N-WASP
and WAVE. A previous study demonstrated that astrocytes
exclusively express the ubiquitous WAVE2 isoform, with
undetectable levels of WAVE1 and WAVE3 (Kim et al., 2006).
We used a published siRNA sequence (Danson et al., 2007),
which reduces endogenous WAVE2 expression to 27.4%67.2 in
cultured astrocytes (Fig. 4A). Most WAVE2-depleted cells acquired
a stellate morphology following forskolin treatment, and the
proportion of polygonal cells was not significantly changed from
controls (Fig. 4B–D). To further investigate whether the depletion of
WAVE2 affected astrocyte arborization, we employed Sholl
analyzes, and specifically analyzed astrocytic processes of stellate
astrocytes (with a cell-outline:cell-area ratio greater than 0.2) not
including cell bodies. Despite a high variance, we were able to
determine a significantly decreased complexity in WAVE2-depleted
astrocytes (Fig. 4E). These findings demonstrate that WAVE2 is
involved in organizing astrocytic processes, however knocking
down WAVE2 did not completely block changes in astrocyte
morphology, as observed upon Arp2/3 inhibition (see Fig. 1).
We carried out similar experiments to examine the role of N-
WASP. A previously characterized siRNA (Kovacs et al., 2011)
reduced endogenous N-WASP to 33%62.4 of its normal level in
Fig. 2. Acute inhibition of the Arp2/3 complex in astrocytes in brain slices. (A) Demonstration of a modified tissue clearance procedure, allowing deep-tissue
antibody staining and imaging by confocal microscopy. Untreated cortical slice (top) in comparison to cleared tissue (bottom). (B) Z-projection of a control
astrocyte 40 mm within the cortical slice, previously stained for DNA (Hoechst 33258), GFAP and S100b, as acquired by confocal microscopy after tissue
clearance. Scale bars: 10 mm. (C) Filament tracing of GFAP- and S100b-positive processes in an individual astrocyte. Main processes were defined by GFAP
immunoreactivity (top). Fine structures were determined by S100b immunoreactivity (center). Overlay of 3D models and confocal z-projections (bottom). Left
panels: control astrocyte. Right panels: astrocyte from a slice treated with CK-548. Scale bars: 10 mm. (D) Quantification of longest processes in control and CK-
548-treated astrocytes, based on GFAP immunoreactivity. n520 per condition, P.0.05 (unpaired Student’s t-test). (E) Sholl analyzes on combined GFAP- and
S100b-positive processes in control (blue) and CK-548-treated (red) astrocytes. n520 per condition, **P,0.005, ***P,0.0005 (unpaired Student’s t-test and
Sidak–Bonferroni method). (F) Quantification of soma volumes from control and CK-548-treated astrocytes. n520 per condition, ***P,0.0005 (unpaired
Student’s t-test). (G) Frequency of individual S100b-positive process volumes from control and CK-548-treated astrocytes. (90,000 S100b-positive processes
from 20 cells per condition). Left graph: small processes up to 1.25 mm3. Right graph: larger processes greater than 1.5 mm3.
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astrocytes (Fig. 4F). In contrast to WAVE2-deficient cells,
astrocytes with reduced N-WASP expression showed a complete
block of stellation, and remained in a polygonal morphology
(Fig. 4G–I). This demonstrates that N-WASP is required for the
development of the typical astrocyte morphology, and strongly
suggests that N-WASP is the major Arp2/3 activator in this
process.
Depletion of the Arp2/3 inhibitor PICK1 leads to increased
astrocyte complexity
Given that astrogliosis involves cell body expansion and reduced
astrocyte complexity, and our data demonstrate a role for Arp2/3
inhibition in this process, we investigated the role of an
endogenous Arp2/3 inhibitory protein that might function
antagonistically to N-WASP. We previously defined PICK1 as
Fig. 3. Inhibition of formins and Myosin II counteracts Arp2/3 inhibition and is associated with changes in small GTPase activation. Images (left) and
frequency analysis (right) for astrocytes after serum starvation, forskolin and subsequent incubation with DMSO (A), CK-548 (B), CK-548 plus the formin
inhibitor SMIFH2 (C), CK-548 plus blebbistatin (D) and CK-548 plus the ROCK inhibitor Y-27632 (E). Scale bars: 10 mm. Cell morphology is visualized by
Alexa-546–phalloidin staining. Graphs show quantification of astrocyte morphology following the drug treatments (n5300 cells per condition from three
independent experiments). (F) Quantification of the proportion of polygonal astrocytes after the treatments shown in A–E. *P,0.05, **P,0.005 (ANOVA
followed by Bonferroni’s correction). (G) Determination of RhoA activation in astrocytes after forskolin treatment followed by CK-548 treatment for 1 h. Upper
blots indicate total RhoA levels, lower blots show the GTP-bound fraction. The graph shows a quantification of the relative proportion of active RhoA, as shown in
the western blots. n55, *P,0.05 (unpaired Student’s t-test). (H) Determination of Rac1 activation in astrocytes after forskolin treatment, followed by CK-548
treatment for 1 h. Upper blots indicate total Rac1 levels, lower blots show the GTP-bound fraction. The graph shows a quantification of the relative proportion of
active Rac1, as shown in the western blots. n54. *P.0.05 (unpaired Student’s t-test).
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an Arp2/3 inhibitor that can oppose N-WASP in actin
polymerization assays (Rocca et al., 2008). To manipulate
PICK1 levels in astrocytes, we used a recently published
shRNA sequence (Citri et al., 2010) to design synthetic siRNA,
which depletes endogenous PICK1 in astrocytes to 6%64 of
control levels (Fig. 4J). Showing the opposite effect to depletion of
N-WASP or Arp3, PICK1 knockdown results in increased
branching of astrocytic processes after forskolin treatment
(Fig. 4K–M). Because this treatment leads to increased
complexity, there is no significant change in the proportion of
Fig. 4. Identification of Arp2/3 regulators in astrocytes. (A) Astrocytes were transfected with control siRNA (siControl) or WAVE2-specific siRNA
(siWAVE2). WAVE2 and GAPDH expression were analyzed by western blotting. (B) Confocal images of siControl- and siWAVE2-transfected astrocytes,
subjected to by serum starvation, forskolin treatment and phalloidin staining. Scale bars: 10 mm. (C) Frequency analysis of the astrocyte complexity in WAVE2-
knockdown and control cells after forskolin treatment. For frequency analysis, n5300 cells per condition from three independent experiments. (D) Quantification
of the proportion of polygonal astrocytes of siControl- and siWAVE2-transfected cells, *P,0.05 (unpaired t-test). (E) Sholl analysis on processes of astrocytes
transfected with either control siRNA (siControl, blue) or siWAVE2-specific siRNA (siWAVE2, red). n5108 (siControl), n5140 (siWAVE2), *P,0.05
(unpaired t-test and Sidak-Bonferroni method). (F) Astrocytes were transfected with control siRNA (siControl) or N-WASP-specific siRNA (siN-WASP). N-
WASP and GAPDH expression were analyzed by western blotting. (G) Confocal images of astrocytes after transfection with control siRNA (siControl) or N-
WASP-specific siRNA (siN-WASP), followed by serum starvation, forskolin treatment and phalloidin staining. Scale bars: 10 mm. (H) Frequency analysis of
astrocyte complexity of N-WASP-knockdown and control cells after forskolin treatment. For frequency analysis, n5300 cells per condition from three
independent experiments. (I) Quantification of the proportion of polygonal astrocytes from control (siControl) and N-WASP-depleted cells (siN-WASP), as shown
in H. **P,0.005 (unpaired Student’s t-test). (J) Astrocytes were transfected with control siRNA (siControl) or PICK1-specific siRNAs (siPICK1). PICK1 and
GAPDH expression were analyzed by western blotting. (K) Confocal images of astrocytes after transfection with control siRNA (left) and PICK1-specific siRNA
(right), stained with actin and PICK1-specific antibodies. Before fixation and immunocytochemistry, cells were serum-starved and treated with forskolin. Scale
bars: 10 mm. (L) Frequency analysis of astrocyte complexity of PICK1-knockdown and control cells after forskolin treatment (300 cells per condition from three
independent experiments in each frequency analysis). (M) Sholl analysis on processes of astrocytes transfected with either control siRNA (siControl, blue) or
PICK1-specific siRNA (siPICK1, red). n5108 (siControl), n582 (siPICK1), *P,0.05 (unpaired Student’s t-test and Sidak–Bonferroni method).
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polygonal astrocytes following PICK1 knockdown (supplementary
material Fig. S2). PICK1 depletion does not affect cell morphology
or actin organization in polygonal astrocytes that were not treated
with forskolin (supplementary material Fig. S3A).
Taken together, these experiments demonstrate a role for N-
WASP and WAVE2 as Arp2/3 activators, and PICK1 as an Arp2/3
inhibitor with opposing roles in regulating astrocyte morphology.
Knockdown of PICK1 inhibits morphological changes in
astrocytes following oxygen and glucose deprivation
To directly test whether the manipulation of the Arp2/3-complex
machinery can influence injury-associated changes in astrocyte
morphology, we knocked down PICK1 using siRNA and exposed
these cells to oxygen and glucose deprivation (OGD), an in vitro
model for ischemia. Within 20 min of OGD, control astrocytes
Fig. 5. PICK1 knockdown inhibits morphological changes in astrocytes in response to OGD. (A) Confocal images of serum-starved and forskolin-treated
astrocytes before and after 20 min of OGD. Cell morphology was visualized by F-actin staining with phalloidin–Alexa-546. Scale bars: 10 mm. (B) Frequency
analysis on complexity of control astrocytes before and after 20 min OGD (n5300 cells per condition from three independent experiments for each frequency
analysis). (C) Frequency analysis on cell complexity of PICK1-deficient astrocytes before and after 20 min OGD (n5300 cells per condition from three
independent experiments for each frequency analysis). (D) Direct comparison of cell complexities of control and PICK1-deficient astrocytes after 20 min OGD.
(E) Quantification of the proportion of polygonal astrocytes, as shown in B, C and D. ***P,0.0005 (ANOVA with Bonferroni’s correction). (F) Confocal images
of serum-starved and forskolin-treated siControl- and siPICK1-transfected astrocytes after 20 min OGD, followed by 3 h reperfusion with oxygenated and
glucose-containing basal medium. Visualization of morphology by F-actin staining with phalloidin–Alexa-546. Scale bars: 10 mm. (G) Frequency analysis on cell
complexity of control astrocytes after 20 min OGD, and after 20 min OGD and 3 h of reperfusion (OGD/RPF) (n5300 cells per condition from three independent
experiments for each frequency analysis). (H) Frequency analysis on cell complexity of PICK1-deficient astrocytes after 20 min OGD, and after 20 min OGD and
3 h of reperfusion of reperfusion (OGD/RPF) (n5300 cells per condition from three independent experiments for each frequency analysis). (I) Frequency analysis
on cell complexity of control and PICK1-deficient astrocytes after 20 min OGD and 3 h of reperfusion (OGD/RPF). (J) Quantification of the proportion of
polygonal astrocytes, as shown in G, H and I. ***P,0.0005 (ANOVA with Bonferroni’s correction). (K) Confocal images of serum-starved and forskolin-treated
astrocytes after 5 min of OGD with either DMSO or CK-548. Cell morphology was visualized by F-actin staining with phalloidin–Alexa-546. Scale bars: 10 mm.
(L) Frequency analysis of astrocytes after 5 min OGD and treated with either DMSO or CK-548 (n5300 cells per condition from three independent experiments
for each frequency analysis). (M) Quantification of the proportion of polygonal astrocytes, as shown in L. **P,0.0005 (unpaired Student’s t-test).
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completely lose their typical stellated astrocyte morphology and
acquire a polygonal cell morphology, which is accompanied by a
substantial increase in visible actin fibers (Fig. 5A,B,D,E).
Interestingly, PICK1-depleted astrocytes exhibit dramatically
reduced OGD-dependent astrocyte expansion (Fig. 5A,C,D,E),
strongly suggesting that PICK1 is required for injury-associated
changes in astrocyte morphology that occur during astrogliosis.
After cerebral ischemia, brain cells undergo so-called
reperfusion injuries caused by free radicals when the blood
circulation has been restored (Alexandrov 2010). We simulated
this condition after OGD by reperfusing cultured cells with
oxygenated glucose-containing medium for 3 h, which evokes
further formation of thick actin fibers (Fig. 5F). There is no
further change in overall morphology (Fig. 5G). In contrast, a
substantial subset of PICK1-depleted astrocytes do not acquire a
complete polygonal cell shape and still exhibit slender processes
even after 3 h of reperfusion (Fig. 5F,H–J). Although the
remaining PICK1-deficient cells acquire a polygonal shape
after reperfusion, these astrocytes do not show the same level
of cell expansion and actin fiber formation as control cells after
reperfusion (Fig. 5F). These results suggest that Arp2/3
inhibition by PICK1 leads to astrocyte expansion during OGD.
To directly test whether OGD-induced astrocyte expansion
requires Arp2/3 inactivation, we performed a ‘sub-threshold’
OGD experiment. A 5-min OGD treatment has only minor effects
on astrocyte morphology (Fig. 5K–M), and CK-548 alone also
has no detectable effect within 5 min (Fig. 1G). In contrast, the
addition of CK-548 leads to a rapid increase in the number of
polygonal astrocytes within 5 min of OGD (Fig. 5K–M).
Arp2/3 overactivation by N-WASP blocks astrocyte
expansion during OGD
To further explore the mechanism behind OGD-induced astrocyte
expansion, we overexpressed GFP-tagged N-WASP variants.
Compared with control cells transfected with GFP, N-WASP
overexpressing astrocytes exhibit fewer stress fibers
(supplementary material Fig. S3B). Moreover, a constitutively
active mutant of N-WASP, D226-267 (Stamm et al., 2005),
radically alters F-actin organization in polygonal astrocytes
(supplementary material Fig. S3B). We assume that the
differences in actin organization between astrocytes expressing
N-WASP WT and N-WASP D226–267 are based on the fact that
the activity of overexpressed N-WASP WT relies on upstream
signaling pathways present in the transfected astrocytes. All
transfected cells expressing either GFP or N-WASP variants
acquire a stellate morphology by forskolin treatment (Fig. 6A).
During OGD, 72.3%66.1 of GFP-expressing control cells
expand to a polygonal morphology (Fig. 6B–D). In astrocytes
overexpressing GFP-tagged wild-type (WT) N-WASP,
destellation is markedly inhibited, and only 43.3%69 of cells
exhibit a polygonal morphology after OGD (Fig. 6B–D). Before
OGD, all GFP–N-WASP-D226–267-expressing astrocytes
exhibit a stellate morphology and exhibit a frequency of
polygonal cells, analogous to astrocytes overexpressing N-
WASP-WT (Fig. 6D). However, stellate N-WASP-D226–267-
expressing cells tend to be a higher cell-outline:cell-area ratio
than astrocytes transfected with N-WASP WT (Fig. 6C).
Taken together, these results demonstrate that the level of
Arp2/3 activation, controlled by PICK1 and N-WASP, defines
astrocyte morphological complexity under conditions relating to
ischemic injury.
Discussion
In this study, we investigated the role of the Arp2/3 complex and
associated signaling in astrocytes. We demonstrate that the
expansion of astrocytic cell bodies and processes is triggered by
Arp2/3 inhibition in dissociated cultures and brain tissue. This
phenomenon requires the activity of myosin II in conjunction
with increased RhoA activity. Furthermore, we identified N-
WASP and PICK1 as crucial Arp2/3 regulators in astrocyte
Fig. 6. Arp2/3 stimulation by N-WASP
overexpression inhibits OGD-dependent changes in
astrocyte morphology. Astrocytes were transfected
with GFP, GFP–N-WASP WT or constitutively active
GFP–N-WASP-D227–267. (A) Confocal images of
transfected, serum-starved and forskolin-treated
astrocytes before OGD, stained with phalloidin–
Alexa-546. Scale bars: 10 mm. (B) Confocal images of
transfected astrocytes after 20 min OGD and stained
for F-actin. Scale bars: 10 mm. (C) Frequency analysis
of complexity of astrocytes transfected with GFP, N-
WASP WT and N-WASP-D227–267 after OGD. For
this analysis only cells with exogenous N-WASP in
the cytosol and nuclei were taken into account (300
cells per condition from three independent
experiments were used in each frequency analysis).
(D) Quantification of the proportion of polygonal
astrocytes, as shown in C. *P,0.05 (unpaired
Student’s t-test).
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morphological plasticity, and show that this mechanism underlies
the rapid and drastic morphological changes exhibited by
astrocytes under ischemic conditions.
In most studied cell types, inactivation of the Arp2/3 complex
leads mainly to disappearance, outgrowth-inhibition or shrinkage
of subcellular structures such as lamellipodia in fibroblasts and
cancer cells (Steffen et al., 2006; Wu et al., 2012), or neurites and
dendritic spines in neurons (Korobova and Svitkina, 2008;
Hotulainen et al., 2009; Tahirovic et al., 2010; Nakamura et al.,
2011; Yang et al., 2012). Acute inactivation of the Arp2/3
complex in astrocytes has the opposite effect, and leads to cell
body expansion. This demonstrates that astrocytes employ the
actin cytoskeleton in a distinct manner to define their
morphology, compared to other cell types. Although astrocytes
are capable of acquiring morphologies similar to non-neuronal
cells and neurons, our results show that the Arp2/3-dependent
mechanisms used for these morphological changes are different
in astrocytes compared with other cell types.
Our small-molecule inhibitor and RNAi experiments indicate
that astrocytes require a high tonic activation of the Arp2/3
complex through N-WASP or WAVE to obtain and maintain
their typical stellate morphology. This suggests that the Arp2/3
complex forms an actin network that provides membrane tension
to maintain a complex stellate morphology. Furthermore, our
results show that the Arp2/3-dependent expansion of astrocytes to
a polygonal morphology can be prevented by the inhibition of
myosin II and its upstream activator ROCK, indicating that
myosins play a key role during the transition from stellate to
polygonal astrocytes. Actin arrays formed by the Arp2/3 complex
usually do not contain myosins, which could explain the low
level of active myosin in stellate astrocytes, and a higher level in
polygonal astrocytes (John et al., 2004; Vicente-Manzanares
et al., 2009). This hypothesis is supported by a recent study on the
interplay of the Arp2/3 complex and myosin II in neuronal
growth cones (Yang et al., 2012). In conjunction with previous in
vitro experiments (Janson et al., 1991), these studies suggest that
Arp2/3 activity creates a dense actin network in the cell cortex,
which resists myosin II contractility. A possible mechanism for
myosin-dependent astrocyte expansion could be that the loss of
Arp2/3-dependent actin networks allows the re-distribution of
myosin into the periphery of astrocytes. This is consistent with a
previous study reporting that myosin is particularly enriched in
the periphery of polygonal astrocytes (John et al., 2004). Within
the cell cortex, active myosin could re-organize actin filaments
from destabilizing branched arrays towards bundles followed by
the assembly of larger focal adhesions (Favero and Mandell,
2007; Vicente-Manzanares et al., 2009). Both actin fiber
formation and re-organization of focal adhesions might then
consolidate ‘filling the gap’ membrane progression between
primary astrocyte processes (supplementary material Movie 4) in
a similar manner to a mechanism recently described for Arp2/3-
deficient fibroblasts (Wu et al., 2012). However, these
protrusions appear in astrocytes in a non-polarized manner and
thereby evoke comprehensive cell spreading towards a polygonal
morphology. Further research is necessary to study the precise
nature of actin networks in astrocytes.
Previously, elevated RhoA activity had been detected in
neurons after Arp3 depletion (Korobova and Svitkina, 2008). We
also measured increased levels of active RhoA in CK-548-treated
astrocytes but observed no significant changes in active Rac1.
This coincidence of astrocyte expansion and higher RhoA
activity is consistent with previous studies showing that
inactivation of RhoA and myosin is necessary for astrocytes to
acquire and maintain a stellate morphology (Ramakers and
Moolenaar, 1998; John et al., 2004). The precise mechanism as to
how increased RhoA activity is triggered in stellate astrocytes
upon Arp2/3 inhibition is unknown and requires further
investigation. However, we can exclude the possibility of a
feedback loop in astrocytes mediated through Rac1 inactivation
(Tang et al., 2012), as the levels of active Rac1 are not
significantly changed in CK-548-treated astrocytes (Fig. 3H).
Although we occasionally observe increased filopodia
formation in astrocytes with inactive Arp2/3 complex
(supplementary material Movie 4), our quantification of
stellated astrocytes treated with CK-548 and SMIFH2 does not
provide evidence for a significant contribution of formins to the
transition of stellate astrocytes to polygonal cells (Fig. 3F).
We identify N-WASP as a major Arp2/3 activator that controls
overall astrocyte morphology. Consistent with the Arp2/3 inactivation
experiments, astrocytes with reduced N-WASP levels show defects in
developing a stellate morphology, whereas the knockdown of the only
expressed WAVE isoform (WAVE2) affects only the formation of
astrocytic processes. These results might indicate a crucial role for N-
WASP as Arp2/3 activator for the general astrocyte morphology,
whereas WAVE2 modulates the fine organization of astrocytic
processes. Analogous to SCAR and WAVE knockouts in
Dicytostelium, it is also conceivable that, in astrocytes, N-WASP
and WAVE2 might share functions in Arp2/3 regulation but that N-
WASP compensates for the loss of WAVE2 (Veltman et al., 2012).
Conversely, PICK1 knockdown promotes astrocyte complexity and
thereby evokes the opposite phenotype to Arp3, N-WASP or
WAVE2 depletion. Antagonism between PICK1 and N-WASP
has been observed before in in vitro actin polymerization assays
(Rocca et al., 2008), but not in cell physiology. The importance of
the opposing roles of PICK1 and N-WASP in vivo is highlighted in
situations of ischemic injury. We analyzed the effect of OGD on
stellated astrocytes, which exhibit rapid changes in morphology
during brief exposures to ischemic conditions. Overactivating the
Arp2/3 complex by PICK1 depletion or N-WASP overexpression
inhibits OGD-induced morphological changes. In contrast,
pharmacological Arp2/3 inhibition during OGD rapidly
accelerates (within a few minutes) the expansion of astrocytes
from stellate to polygonal cells. Our results suggest that there could
be a switch in Arp2/3 activity within astrocytes during ischemia. In
the healthy CNS, high levels of active N-WASP provide a tonic
activation of the Arp2/3 complex, and thereby maintain the typical
astrocyte morphological complexity. During ischemia, the Arp2/3
complex is inhibited by PICK1, resulting in the previously
described mechanism for astrocyte expansion. This hypothesis is
supported by the recent description of elevated levels of PICK1 in
reactive astrocytes in an animal model of amyotrophic lateral
sclerosis (ALS) (Focant et al., 2013). In summary, our findings
show that astrocytes use a balance of Arp2/3 activation and
inhibition through N-WASP, WAVE2 and PICK1 to maintain and
modulate their morphology. This mechanism underlies the
morphological changes associated with astrogliosis that occur in
response to CNS injury.
Materials and Methods
Ethical approval
Animal care and experimental procedures were conducted in accordance with
British animal protection legislation and experimental protocols approved by the
British National Committee for Ethics in Animal Research.
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Cell culture
Cortical astrocytes were isolated from brains of postnatal rats (P2). Cerebral
cortices were isolated, mechanically dissociated in HBSS and trypsinized
(Invitrogen, Paisley, UK) for 15 min at 37 C˚. Afterwards, trypsin (Invitrogen)
was inhibited by triturating cells in complete Dulbecco’s modified Eagle’s medium
(DMEM) (Lonza, Slough, UK) with 10% FBS. Cell suspensions were
subsequently plated into T75 flasks (Greiner-BioOne, Frickenhausen, Germany),
coated with 0.025% collagen and 100 mg/ml poly-L-lysine. Astrocytes were
cultivated till confluency and, subsequently, plated for imaging or biochemical
experiments. Microglia were erased by treating astrocytes cultures at high density
for 90 min with 60 mM L-leucine-methylester in complete medium (Hamby et al.,
2006). Contaminations by other cell types were prevented by plating astrocytes
onto uncoated glass coverslips (Silva et al., 1998) or glass-bottomed dishes
(MaTek Corporation, Ashland, MA, US). For western blotting, L-leucine-
methylester-treated astrocytes were plated onto plastic six-well plates (Greiner-
BioOne), coated with 0.025% collagen and 100 mg/ml poly-L-lysine. Acute
cortical slices (P14) were obtained as described previously (Perugini et al., 2012).
Cortical and hippocampal rat neurons were prepared and cultured as published
previously (Nakamura et al., 2011). Murine embryonic fibroblasts were kindly
provided by Chun Guo (University of Bristol, Bristol, UK). MDA-MB-231 and
HEK293T cells were cultivated in complete DMEM medium with 10% FBS on
uncoated plastic dishes.
Pharmacological treatments
Stellation of dissociated astrocytes was induced by 2 h of serum starvation in
DMEM medium and subsequent incubation with 10 mM forskolin in DMEM for
2 h. Stellated astrocytes were then used for destellation experiments with 75 mM
CK-548 in DMEM. The following reagents were used in conjunction with CK-548
for 2 h on previously stellated astrocytes: SMIFH2 (75 mM), Blebbistatin
(100 mM) and Y-27632 (25 mM). In all experiments, DMSO served as vehicle
control. All reagents were purchased from Sigma-Aldrich (St Louis, MO, US).
Acute slices were placed in oxygenated artificial cerebrospinal fluid (aCSF) and
incubated for 2 h with either CK-548 or vehicle control.
siRNAs
siRNAs were transfected into astrocytes using Lipofectamine RNAiMax:
astrocytes were transferred into serum-free Opti-MEM (Invitrogen) and
transfected with siRNAs, as published previously (Benfenati et al., 2011). After
4 h of incubation, serum was added to transfected cells, obtaining a final
concentration of 10% FBS. On the following day, Opti-MEM was replaced with
DMEM-based cultivation medium, as described above. To increase the
transfection efficiency, this procedure was repeated 3 days after the initial
transfection. siRNAs directed against Arp3 (Korobova and Svitkina, 2008) and
WAVE2 (Danson et al., 2007) were purchased from Dharmacon (Lafayette, CO,
US). The N-WASP-specific siRNA, based on a previously published shRNA
(Kovacs et al., 2011), was purchased from Sigma-Aldrich. The PICK1-specific
siRNA is based on a validated shRNA sequence (Citri et al., 2010) and was
purchased from Sigma-Aldrich. The unspecific siRNA (59-
AGGUAGUGUAAUCGCCUUGTT-39) was purchased from Eurofins MWG
(Regensburg, Germany).
Plasmids and transfection
Constructs encoding for GFP fusion proteins of either wild-type N-WASP
(pEGFP-C1-N-WASP WT, Lommel et al., 2001) or the constitutively active N-
WASP mutant (pEGFP-C1-N-WASP D227–267, Stamm et al., 2005) were a
generous gift by Theresia Stradal (University of Mu¨nster, Germany). pEGFP-C2
served as negative control. Plasmid DNA was transfected into astrocytes by using
Lipofectamine LTX (Invitrogen), as described previously (Benfenati et al., 2011),
with the above mentioned medium changes used for siRNA transfection.
Antibodies and reagents
Mouse anti-b-actin AC-15 (Sigma-Aldrich, IF 1:1000), mouse anti-Arp3 [Sigma-
Aldrich; 1:200 for immunofluorescence (IF), 1:1000 for western blot (WB)],
mouse anti-S100b SH-B1 [Sigma-Aldrich; 1:1000 for immunohistochemistry
(IHC)], guinea pig anti-GFAP (Synaptic Systems, Go¨ttingen, Germany; IF 1:500,
IHC 1:400), rabbit anti-WAVE2 D2C8 (Cell Signaling, Beverly, MA; WB
1:1000), rabbit anti-N-WASP #4848 (Cell Signaling; WB 1:1000), mouse anti-
GAPDH 6C5 (Abcam, Cambridge, UK; WB 1:20,000), rabbit anti-RhoA (Cell
Signaling; WB 1:1000), mouse anti-Rac1 610651 (BD Biosciences, Franklin
Lakes, NW; WB 1:1000), mouse anti-PICK1 L20/8 (Antibodies Incorporated,
Davis, CA; WB 1:1000), chicken anti-PICK1 NBP1-42829 (Novus Biological,
Littleton, CO; IF 1:300). Horseradish peroxidase (HRP)-conjugated secondary
antibodies were purchased from Millipore. Cyanine dye conjugated and cross-
absorbed secondary antibodies (IgGs) were purchased from Stratech (Newmarket,
UK). Filamentous actin was labeled with Alexa Fluor (Alexa 546, Alexa 633)-
conjugated phalloidin (Invitrogen). DNA staining was carried out using Hoechst
33258 (Invitrogen).
Immunocytochemistry
Indirect immunofluorescence with formaldehyde fixation only was performed as
described previously (Murk et al., 2009). Immunofluorescence for PICK1
required methanol fixation. Astrocytes were fixed and permeabilized in –20 C˚
cold methanol for 3 min. Subsequent immunostaining was carried out, as
described in the mentioned reference. After methanol fixations cell morphology
was visualized by antibody staining for b-actin. Cells were imaged on either LSM
510 Meta (Zeiss, Jena, Germany) or Leica SP5-II (Leica, Heidelberg, Germany)
confocal microscopes using a 406 objective (1.3 NA) and a multitrack mode to
acquire individual channels separately. Image processing was performed in
ImageJ.
Deep tissue Immunohistochemistry and tissue clearance
A recently published protocol to clear brain tissue (Hama et al., 2011) was
modified to allow its combination with whole-mount immunohistochemistry. After
the above mentioned pharmacological treatments, 400-mm thick slices from the rat
motor cortex (P14) were fixed for 1 h in 4% (w/v) formaldehyde in PBS at 4 C˚.
After three washes in PBS, slices were permeabilized in 2% (v/v) Triton-X100 in
PBS overnight. After three subsequent washes in PBS, slices were incubated with
20% BSA in PBS for 1 h, then incubated with primary antibodies in PBS with
0.1% Tween-20 (PBS-T) for 36 h. After repetitive washes with PBS and a
subsequent incubation in 20% BSA in PBS, slices were incubated with species-
cross-absorbed secondary antibodies in PBS-T for a further 36 h. Nuclei were
stained by the application of 0.5 mg/ml Hoechst 33258 (Invitrogen) for 5 min at
room temperature. To avoid the denaturation of antibodies by the Scale reagent,
stained slices underwent an additional fixation with 4% formaldehyde in PBS for 1
h at 4 C˚. Afterwards, fixed cultures were incubated in ScaleA2 for 4 days at 4 C˚,
followed by another 2 days with ScaleB4. Finally, slices were mounted and imaged
with a single photon confocal microscope (Leica SP5, Leica) using a standard 636
immersion objective (NA 1.7). Astrocytes were acquired in multitrack mode as z-
stacks with 1-mm thick confocal sections.
Live-cell imaging
The phase-contrast supplementary material movies were recorded in Phenol-Red-
free DMEM at 37 C˚ and 5% CO2 with a Leica AS-MDW live-cell imaging
workstation (Leica) equipped with Roper CoolSnap HQ 12-bit monochrome CCD
camera, Maerzhaeuser scanning stage and environmental control chamber (Solent,
Segensworth, UK) with long-term temperature control and CO2 enrichment. For
live imaging, a 406 objective (1.3 NA) was used. Images were acquired every
minute in a multi-acquisition mode and assembled into movies using Volocity
software (Perkin-Elmer, Waltham, MA, US).
Oxygen/Glucose deprivation (OGD)
OGD was performed within a MACS-VA500 anaerobic workstation (Don Whitley
Scientific Limited, Shipley, UK) supplemented with 95% N2 and 5% CO2 at 37 C˚
for 5 or 20 min. Astrocytes were washed twice with deoxygenated serum-free
DMEM without glucose (Invitrogen) and were then maintained in this medium
under anaerobic conditions. Immediately after OGD, cells were washed once with
16 PBS and fixed for 20 min with 4% formaldehyde followed by phalloidin
staining. In some experiments, reperfusion with oxygenated and glucose-
containing DMEM without serum followed OGD treatments: astrocytes were
transferred from the anaerobic workstation into a humidified and air-supplemented
incubator and incubated at 37 C˚ and 5% CO2 for 3 h.
GTPase activation assays
Isolation of active GTPases from lysates by pulldown assays was performed as
described previously (Pellegrin and Mellor, 2008).
Morphological analysis
Dissociated astrocytes were categorized into polygonal and stellate astrocytes by
calculating the ratio of cell outlines and total cell areas with Fiji software
(Schindelin et al., 2012). Low-density cultures were used and single stellate
astrocytes were filament-traced by Imaris to allocate processes to individual cells
(Bitplane, Zurich, Switzerland) before cropping in Fiji. Astrocytes were defined as
polygonal if they had a cell-outline:cell-area ratio ,0.2. Changes in the proportion
of polygonal astrocytes upon different treatments were statistically determined in
the same manner as in previous studies (Burgos et al., 2007; Favero and Mandell,
2007). Complexities of astrocyte processes, without taking the cell body into
account, were measured by Sholl analysis using the filament tracer of the Imaris
software. To study morphological properties of astrocytes within tissue, only
astrocytes in layer 2 or 3 of the motor cortex and at a depth of 15- to 65-mm within
the tissue were taken into account. Signal-to-noise ratio was improved by using the
‘despeckle’ function in Fiji. Files were then exported to Imaris software and further
processed by 3D cropping of individual cells, baseline thresholding and gausian
filtering. Astrocyte morphology was determined by using the Imaris filament
tracer, whereas GFAP-positive processes of individual astrocytes were traced first
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and used as main tracks to determine smaller and branched processes positive for
S100b.
Statistical analyses
To determine statistical significance in results obtained from GTPase activation
assays and measurements on proportions of polygonal astrocytes, an unpaired
Student’s t-test with Welch’s correction was performed. For multiple analyzes,
data were analyzed by using ANOVA followed by Bonferroni’s corrections. Sholl
analyzes were assessed using unpaired Student’s t-tests and the Sidak–Bonferroni
method. On all graphs, error bars are standard deviations. P-values are defined as
followed: *P,0.05, **P,0.005, ***P,0.0005. Statistical tests were calculated
by using Excel 2010 (Microsoft) and Graphpad Prism 6 (Graphpad Software, San
Diego, CA).
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Fig. S1. Levels of Arp3 do not significantly differ in astrocytes, compared to other cell types. (A) Lysates of cortical astrocytes, 
hippocampal neurons, cortical neurons, primary embryonic fibroblasts, MDA-MB-231 cancer cells and HEK293T cells were analysed 
for the expression levels of Arp3 and GAPDH by Western blotting. (B) Quantification of Arp3 levels in cells displayed in (A). n=5-6, 
*p < 0.05 (ANOVA followed by Bonferroni`s correction)
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Fig. S2. Quantification of polygonal astrocytes after PICK1 depletion and forskolin treatment. Quantification of the proportion 
of polygonal astrocytes after PICK1 depletion followed by serum starvation and forskolin treatment, as shown in Figure 4L. *p < 0.05 
(unpaired t-test).
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Fig. S3. Study of PICK1 depletion and overexpressed N-WASP variants in polygonal astrocytes. (A) Confocal images of 
polygonal astrocytes transfected with control (siControl) and PICK1 (siPICK1) specific siRNAs, followed by fixation and phalloidin 
staining. Bars: 10 µm. (B) Confocal images of polygonal astrocytes transfected with GFP, GFP-N-WASP WT or constitutively active 
GFP-N-WASP-∆227-267, stained with phalloidin. Bars: 10 µm.
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Figure S3
Movie 1. Time-lapse video of control astrocytes treated with forskolin. Serum starved astrocytes were treated with forskolin in 
basal medium and observed under phase-contrast for one hour. Video begins immediately after adding forskolin.
Movie 2. Time-lapse video of astrocytes simultaneously treated with forskolin and CK-548. As in Movie 1, cells were previously 
serum-starved and then recorded for one hour immediately after adding CK-548 and forskolin. 
Movie 3. Time-lapse video of astrocytes after forskolin washout in DMSO containing medium. Astrocytes were stellated as 
shown in Movie 1 and subsequently incubated in DMSO supplemented serum-free medium. Video was recorded for 1 hour.
Movie 4. Time-lapse video at high magnification on an individual astrocyte incubated with CK-548 after forskolin removal. 
Time-lapse recording of a stellate astrocyte at high magnification treated for one hour with CK-548 after forskolin washout. Note the 
filopodia formation and membrane blebbing which lead to cell expansion. Video recording started right after addition of CK-548.
Movie 5. Visualizing of antibody labeled astrocytes in brain slices after tissue clearance. Series of X-Y images of 3D 
reconstruction data acquired from an acute cortical slice after tissue clearance and staining for GFAP (green) and DNA (blue). 
Confocal sections (2 µm thickness) were acquired with a standard single photon microscope and 40x objective (NA 1.3) to a depth 
of 120 µm. In this example, settings for laser power and detector gain were kept constant. Note that beyond the areas traumatized by 
slicing, typical astrocytes as well as blood vessels ensheathed by astrocytic endfeet are visible.
Movie 6. Insight into a 3D reconstruction of an immunohistochemically labeled astrocyte. To demonstrate the detailed 
visualization of astrocyte morphology, a subset of a 3D reconstructed astrocyte is shown as rotating animation. Astrocytic main 
processes are labeled with GFAP specific antibody (red), the complex fine structures with S100β specific antibody (green), DNA by 
Hoechst 33258 staining (blue).
